Outcomes of Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Diseases and Recurrent Clostridioides difficile Infection

Gastroenterology. 2020 Nov;159(5):1982-1984. doi: 10.1053/j.gastro.2020.07.045. Epub 2020 Jul 30.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Clostridium Infections / diagnosis
  • Clostridium Infections / microbiology
  • Clostridium Infections / therapy*
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / microbiology
  • Colitis, Ulcerative / therapy*
  • Crohn Disease / diagnosis
  • Crohn Disease / microbiology
  • Crohn Disease / therapy*
  • Fecal Microbiota Transplantation* / adverse effects
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome*
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Reinfection
  • Treatment Outcome
  • United States
  • Young Adult